Cargando...
Late Pulmonary Embolism after COVID-19 Pneumonia despite Adequate Rivaroxaban Treatment
INTRODUCTION: SARS-CoV-2 infection may predispose patients to thrombotic disease. Patients with COVID-19 pneumonia who are receiving non-vitamin K antagonists or direct oral anticoagulants for chronic disease are usually switched to heparin treatment during hospitalization. However, information abou...
Gardado en:
| Publicado en: | Eur J Case Rep Intern Med |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
SMC Media Srl
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7350955/ https://ncbi.nlm.nih.gov/pubmed/32665940 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12890/2020_001790 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|